Gleason&;s classification used for-
## **Core Concept**
Gleason's classification is a system used for grading prostate cancer based on the microscopic appearance of the tumor tissue. It assesses the differentiation of cancer cells and their glandular formation. This grading system helps in predicting the aggressiveness and prognosis of prostate cancer.
## **Why the Correct Answer is Right**
The correct answer, **Prostate cancer**, is associated with Gleason's classification because this system specifically evaluates the architectural pattern of glandular differentiation in prostate cancer tissues. The Gleason score ranges from 2 to 10, with higher scores indicating a worse prognosis. The score is calculated by adding the grades of the two most prevalent patterns of tumor growth. This system is widely used for predicting the behavior of prostate cancer and guiding treatment decisions.
## **Why Each Wrong Option is Incorrect**
- **Option A:** Breast cancer - Incorrect because breast cancer grading and classification involve different systems, such as the Nottingham histologic score or the Scarff-Bloom-Richardson grading system.
- **Option B:** Lung cancer - Incorrect because lung cancer is typically staged using the TNM system, and while grading systems exist, Gleason's classification is not used for lung cancer.
- **Option C:** Colorectal cancer - Incorrect because colorectal cancer staging primarily uses the TNM system, and grading systems like the WHO grading system are used, but not Gleason's classification.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the Gleason score has been updated, and currently, a Grade Group system is used alongside it, which categorizes prostate cancers into five groups based on the Gleason score: Grade Group 1 (Gleason score β€6), Grade Group 2 (Gleason score 7(3+4)), Grade Group 3 (Gleason score 7(4+3)), Grade Group 4 (Gleason score 8), and Grade Group 5 (Gleason score 9-10). This helps in better risk stratification and treatment planning.
## **Correct Answer:** D. Prostate cancer